Literature DB >> 11275024

Pregnancy-related mortality from preeclampsia and eclampsia.

A P MacKay1, C J Berg, H K Atrash.   

Abstract

OBJECTIVE: To examine the role of preeclampsia and eclampsia in pregnancy-related mortality.
METHODS: We used data from the Centers for Disease Control and Prevention's Pregnancy Mortality Surveillance System to examine pregnancy-related deaths from preeclampsia and eclampsia from 1979 to 1992. The pregnancy-related mortality ratio for preeclampsia-eclampsia was defined as the number of deaths from preeclampsia and eclampsia per 100,000 live births. Case-fatality rates for 1988-1992 were calculated for preeclampsia and eclampsia deaths per 10,000 cases during the delivery hospitalization, using the National Hospital Discharge Survey.
RESULTS: Of 4024 pregnancy-related deaths at 20 weeks' or more gestation in 1979-1992, 790 were due to preeclampsia or eclampsia (1.5 deaths/100,000 live births). Mortality from preeclampsia and eclampsia increased with increasing maternal age. The highest risk of death was at gestational age 20-28 weeks and after the first live birth. Black women were 3.1 times more likely to die from preeclampsia or eclampsia as white women. Women who had received no prenatal care had a higher risk of death from preeclampsia or eclampsia than women who had received any level of prenatal care. The overall preeclampsia-eclampsia case-fatality rate was 6.4 per 10,000 cases at delivery, and was twice as high for black women as for white women.
CONCLUSION: The continuing racial disparity in mortality from preeclampsia and eclampsia emphasizes the need to identify those differences that contribute to excess mortality among black women, and to develop specific interventions to reduce mortality from preeclampsia and eclampsia among all women.

Entities:  

Mesh:

Year:  2001        PMID: 11275024     DOI: 10.1016/s0029-7844(00)01223-0

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  162 in total

Review 1.  Preeclampsia, an implantation disorder.

Authors:  Leslie L Waite; Amy K Atwood; Robert N Taylor
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

2.  Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-10-01

3.  Multiple Soluble TGF-β Receptors in Addition to Soluble Endoglin Are Elevated in Preeclamptic Serum and They Synergistically Inhibit TGF-β Signaling.

Authors:  Yao Wang; Qi Chen; Min Zhao; Kelly Walton; Craig Harrison; Guiying Nie
Journal:  J Clin Endocrinol Metab       Date:  2017-08-01       Impact factor: 5.958

4.  Transcriptional profiling of human placentas from pregnancies complicated by preeclampsia reveals disregulation of sialic acid acetylesterase and immune signalling pathways.

Authors:  S Tsai; N E Hardison; A H James; A A Motsinger-Reif; S R Bischoff; B H Thames; J A Piedrahita
Journal:  Placenta       Date:  2010-12-22       Impact factor: 3.481

5.  The Black-White disparity in pregnancy-related mortality from 5 conditions: differences in prevalence and case-fatality rates.

Authors:  Myra J Tucker; Cynthia J Berg; William M Callaghan; Jason Hsia
Journal:  Am J Public Health       Date:  2006-12-28       Impact factor: 9.308

6.  Dendritic cells derived from preeclampsia patients influence Th1/Th17 cell differentiation in vitro.

Authors:  Jing Wang; Yu-Mei Tao; Xiao-Yan Cheng; Tian-Feng Zhu; Zhi-Fang Chen; Hui Yao; Liang-Xiang Su
Journal:  Int J Clin Exp Med       Date:  2014-12-15

7.  Headache and seizure on postpartum day 5: late postpartum eclampsia.

Authors:  Val E Ginzburg; Bryan Wolff
Journal:  CMAJ       Date:  2009-02-17       Impact factor: 8.262

Review 8.  Preeclampsia and Cerebrovascular Disease.

Authors:  Eliza C Miller
Journal:  Hypertension       Date:  2019-05-06       Impact factor: 10.190

Review 9.  Proteinuria in preeclampsia from a podocyte injury perspective.

Authors:  Daniel E Henao; Moin A Saleem
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

10.  A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Tinnakorn Chaiworapongsa; Offer Erez; Pooja Mittal; Edi Vaisbuch; Shali Mazaki-Tovi; Francesca Gotsch; Samuel S Edwin; Ricardo Gomez; Lami Yeo; Agustin Conde-Agudelo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.